Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,759 total articles

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests

OPKO Health announced the issuance of $125 million in senior secured notes backed by their royalty rights from the mazdutide license agreement with Eli Lilly, thereby expanding their financial relationship with HealthCare Royalty (a KKR business). This transaction provides OPKO with additional non-dilutive capital, preserving long-term participatio…

Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family

Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family

Ethos, a NASDAQ-listed life insurance technology company, announced the signing of Erin Andrews as a national ambassador in its ongoing campaign to make life insurance more accessible, especially targeting underserved demographics such as women and younger families. This follows previous partnerships with prominent sports figures David Ortiz and Bo…

Parker Completes Acquisition of Filtration Group Corporation

Parker Completes Acquisition of Filtration Group Corporation

Parker Hannifin Corporation announced the completion of its acquisition of Filtration Group Corporation, aiming to enhance its filtration technology offerings and global aftermarket presence. The deal is expected to add approximately $1.8 billion in sales for fiscal 2027 and create strong recurring revenue streams, with projected cost synergies of …

Interlink Electronics Reports Second Quarter 2026 Results

Interlink Electronics Reports Second Quarter 2026 Results

Interlink Electronics, Inc. reported a 10.4% increase in Q2 2026 revenue to $3.77 million driven by higher shipments of force-sensing and printed electronics products. The company posted net income of $248,000 for Q2 2026 compared to $100,000 a year earlier and expects a strategic acquisition by October 2026 that will significantly expand operation…

Credit Acceptance Announces New Chief Technology Officer to Advance Digital-First, AI-Enabled Business Evolution

Credit Acceptance Announces New Chief Technology Officer to Advance Digital-First, AI-Enabled Business Evolution

Credit Acceptance Corporation announced the hiring of Jeetu Mirchandani, a veteran technology and AI leader from Amazon, as Chief Technology Officer. Mirchandani will lead the company's engineering and technology strategy to accelerate its digital-first and AI-enabled evolution, aiming to improve customer and dealer partner experiences. His extensi…

Saga Communications, Inc. Reports 2nd Quarter 2026 Results

Saga Communications, Inc. Reports 2nd Quarter 2026 Results

Saga Communications, Inc. reported a 6.5% decrease in net revenue to $26.4 million for Q2 2026 versus the prior year, with operating income declining to $623K and net income to $960K. The company sold telecommunications towers last year improving liquidity, resulting in non-cash rent expense and interest income impacting operating expenses. Despite…

Duos Edge AI Signs Exclusive Term Sheet with 0Lat LLC for Proposed Structured Lease Across 15-Site, 225-Cabinet Edge Data Center Portfolio

Duos Edge AI Signs Exclusive Term Sheet with 0Lat LLC for Proposed Structured Lease Across 15-Site, 225-Cabinet Edge Data Center Portfolio

Duos Edge AI, a subsidiary of Duos Technologies Group, announced a non-binding exclusive term sheet with 0Lat LLC for a proposed structured lease of its 15 edge data center sites totaling 225 cabinets across Texas and Georgia. This lease supports 0Lat's distributed compute infrastructure for edge AI workloads, with a 90-day exclusivity period to fi…

Tron Inc. Announces Plan to Deepen Integration with TRON Ecosystem and Pursue Super Representative Status

Tron Inc. Announces Plan to Deepen Integration with TRON Ecosystem and Pursue Super Representative Status

Tron Inc., the largest publicly traded holder of TRON (TRX) tokens, announced plans to deepen its integration into the TRON DAO ecosystem by pursuing election as a Super Representative (SR) to secure blockchain operations and participate in governance, aiming to generate recurring revenue from network rewards. The company holds over 709 million TRX…

SS Innovations Reports Second Quarter 2026 Financial Results

SS Innovations Reports Second Quarter 2026 Financial Results

SS Innovations International, Inc. reported a 39.4% increase in revenue for Q2 2026 to $13.9 million driven by strong adoption of its SSi Mantra surgical robotic system globally, especially in India. The company installed 30 new systems in the quarter, a 30.4% rise year over year, and expanded its cumulative installed base to 224 systems across 12 …

Live Ventures Reports Fiscal Third Quarter 2026 Financial Results

Live Ventures Reports Fiscal Third Quarter 2026 Financial Results

Live Ventures Incorporated announced fiscal Q3 2026 financial results with revenues of $108.9 million, down 3.2% year-over-year, and an operating income decline to $5.3 million from $8.0 million. While Retail-Entertainment and Steel Manufacturing segments showed revenue growth and improved profitability, Retail-Flooring segment experienced signific…

Dogwood Therapeutics Announces Second Quarter 2026 Financial Results

Dogwood Therapeutics Announces Second Quarter 2026 Financial Results

Dogwood Therapeutics announced its second quarter financial results for 2026, highlighting progress in its Halneuron® Phase 2b trial for Chemotherapy Induced Neuropathy Pain (CINP) with 217 patients enrolled and top-line results anticipated in fall 2026. The company also commenced a long-term extension study and announced a global partnership for t…

PDS Biotech Reports Second Quarter 2026 Financial Results

PDS Biotech Reports Second Quarter 2026 Financial Results

PDS Biotechnology Corporation reported its Q2 2026 financial results and announced a strategic refocus to prioritize the development of PDS0301, its tumor-targeted IL-12 immunocytokine, based on favorable clinical data demonstrating significant improvement in metastatic colorectal cancer outcomes. The company will cease internal investment in PDS01…

SAIC Schedules Second Quarter Fiscal Year 2027 Earnings Conference Call for August 31 at 10 A.M. EDT

SAIC Schedules Second Quarter Fiscal Year 2027 Earnings Conference Call for August 31 at 10 A.M. EDT

Science Applications International Corp. (SAIC) will release its second quarter fiscal year 2027 results before the market opens on August 31, 2026. The company will host a webcast conference call at 10:00 a.m. EDT to discuss operational and financial results, with access and a supplemental presentation available via the Investor Relations section …

Aureus Greenway Holdings Inc. and Powerus Announce Effectiveness of Form S-4 Registration Statement

Aureus Greenway Holdings Inc. and Powerus Announce Effectiveness of Form S-4 Registration Statement

Aureus Greenway Holdings Inc. and Autonomous Power Corporation (Powerus) have received SEC effectiveness for their Form S-4 registration statement, a key step towards completing their proposed business combination. The merger, expected to close in Q4 2026, will rename the combined entity Powerus Corporation and continue trading on Nasdaq under tick…

Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

Cingulate Inc. reported its Q2 2026 financial results, highlighted progress on the CMC requirements for resubmitting its NDA for CTx-1301, a next-generation ADHD treatment candidate, and detailed preparations for commercialization pending FDA approval. The company strengthened its intellectual property portfolio with a new patent for CTx-1301 and i…